{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:06:39Z","timestamp":1763762799557,"version":"3.45.0"},"reference-count":15,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Bumetanide is commonly used to achieve diuresis and alleviate fluid overload in pediatric cardiac intensive care unit (PCICU) patients. This study aims to describe the dosing, efficacy, and safety of bumetanide continuous infusion (CI) regimens used in PCICU patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This single center, retrospective study included patients &lt;6 years of age, admitted to the PCICU who received a bumetanide CI for at least 6 hours. The primary outcome was identifying doses and the total duration of bumetanide CI regimens. Secondary efficacy outcomes were determined by the ability to achieve negative fluid balance within 24 hours and the time to reach negative fluid balance. Secondary safety outcomes were based on the prevalence of electrolyte imbalances and renal impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Data from 90 pediatric patients represented 106 hospital encounters in this study. The median age of our study population was 137 days, with a median weight of 4.3 kg. The dose ranged from 0.005 mg\/kg\/hr to 0.3 mg\/kg\/hr, with a median dose of bumetanide of 0.046 mg\/kg\/hr and a median duration of 5.8 days. The change in serum electrolytes and creatinine during baseline and peak infusion rates was not clinically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This study remains the largest pediatric study to date describing the dosing, efficacy, and safety concerns of bumetanide CI in the PCICU population. However, using a high-dose bumetanide drip &gt;0.1 mg\/kg\/hr may not improve the overall outcome, and future studies can explore specific advantages of its use in neonates undergoing cardiac surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5863\/jppt-24-00050","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:03:37Z","timestamp":1763762617000},"page":"617-622","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Evaluation of Dosing Effects of Bumetanide Continuous Infusions in the Pediatric Cardiac Intensive Care Unit"],"prefix":"10.5863","volume":"30","author":[{"given":"Sukumar Suguna","family":"Narasimhulu","sequence":"first","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Lopez-Colon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giles","family":"Peek","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Brock","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Hernandez-Rivera","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zasha","family":"Vasquez-Colon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavenner","family":"Dibert","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Bleiweis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Philip","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (BW, BK), UF Health Shands Hospital, Congenital Heart Center, Department of Pediatrics (DLC, GP, JJ, JHR, JP, KS, MB, MAB, ZVC, WW, TB, SSN), UF Health Shands Hospital, Gainesville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"1","key":"i2331-348X-30-5-617-b01","series-title":"Pediatr Crit Care Med","first-page":"44","article-title":"Fluid overload in infants following congenital heart surgery","volume":"14","author":"Hazle","year":"2013","unstructured":"Hazle MA, Gajarski RJ, Yu S, et al. Fluid overload in infants following congenital heart surgery. Pediatr Crit Care Med. 2013;14(1):44\u201349."},{"key":"i2331-348X-30-5-617-b02","series-title":"Stat Pearls","article-title":"Loop diuretics","author":"Huxel","year":"2024","unstructured":"Huxel C, Raja A, Ollivierre-Lawrence MD. Loop diuretics. In: Stat Pearls. Treasure Island, FL: Stat Pearls Publishing; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546656\/"},{"issue":"3","key":"i2331-348X-30-5-617-b03","series-title":"Cochrane Database Syst Rev","first-page":"CD003178","article-title":"Continuous infusion versus bolus injection of loop diuretics in congestive heart failure","volume":"2005","author":"Salvador","year":"2005","unstructured":"Salvador DRK, Punzalan FE, Rey NR, et al. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2005;2005(3):CD003178."},{"key":"i2331-348X-30-5-617-b04","series-title":"Lexicomp","article-title":"Bumetanide [pediatric drug information]","unstructured":"Bumetanide [pediatric drug information]. Lexicomp. Hudson, OH: Wolters Kluwer Clinical Drug Information Inc. Accessed September 9, 2022. http:\/\/www.online.lexi.com"},{"issue":"17","key":"i2331-348X-30-5-617-b05","series-title":"Am J Health Syst Pharm","first-page":"1458","article-title":"Bumetanide continuous-infusion dosing in critically ill pediatric patients","volume":"69","author":"Bulkley","year":"2012","unstructured":"Bulkley CF, Johnson PN, Henry E, et al. Bumetanide continuous-infusion dosing in critically ill pediatric patients. Am J Health Syst Pharm. 2012;69(17):1458\u20131461."},{"issue":"2","key":"i2331-348X-30-5-617-b06","series-title":"Pediatr Crit Care Med","first-page":"e19","article-title":"Bumetanide continuous infusions in critically ill pediatric patients","volume":"16","author":"McCallister","year":"2015","unstructured":"McCallister KM, Chhim RF, Briceno-Medina M, et al. Bumetanide continuous infusions in critically ill pediatric patients. Pediatr Crit Care Med. 2015;16(2):e19\u2013e22."},{"issue":"4","key":"i2331-348X-30-5-617-b07","series-title":"Nephron Clin Pract","first-page":"c179","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u2013c184."},{"issue":"4","key":"i2331-348X-30-5-617-b08","series-title":"Crit Care","first-page":"R204","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, et al; Acute Dialysis Quality Initiative workgroup. Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204\u2013R212."},{"issue":"suppl 6","key":"i2331-348X-30-5-617-b09","series-title":"Postgrad Med J","first-page":"72","article-title":"Comparison of intravenous bumetanide and frusemide during open heart surgery","volume":"5","author":"Dunn","year":"1975","unstructured":"Dunn FG, Kerr IC, McQueen MJ, et al. Comparison of intravenous bumetanide and frusemide during open heart surgery. Postgrad Med J. 1975;5(suppl 6):72\u201376."},{"issue":"11","key":"i2331-348X-30-5-617-b10","series-title":"J Clin Pharmacol","first-page":"615","article-title":"Comparison of adverse reactions to bumetanide and furosemide","volume":"21","author":"Tuzel","year":"1981","unstructured":"Tuzel IH. Comparison of adverse reactions to bumetanide and furosemide. J Clin Pharmacol. 1981;21(11):615\u2013619."},{"issue":"11\u201312","key":"i2331-348X-30-5-617-b11","series-title":"J Clin Pharmacol","first-page":"551","article-title":"Protein binding and bilirubin displacing properties of bumetanide and furosemide","volume":"22","author":"Turmen","year":"1982","unstructured":"Turmen T, Thom P, Louridas AT, et al. Protein binding and bilirubin displacing properties of bumetanide and furosemide. J Clin Pharmacol. 1982;22(11\u201312):551\u2013556."},{"issue":"2","key":"i2331-348X-30-5-617-b12","series-title":"Ann Neurol","first-page":"327","article-title":"A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures","volume":"89","author":"Soul","year":"2021","unstructured":"Soul JS, Bergin AM, Stopp C, et al; Boston Bumetanide Trial Group. A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures. Ann Neurol. 2021;89(2):327\u2013340."},{"issue":"1","key":"i2331-348X-30-5-617-b13","series-title":"J Thorac Cardiovasc Surg","first-page":"169","article-title":"Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery [discussion in J Thorac Cardiovasc Surg. 2015;150(1):178\u2013180]","volume":"150","author":"Naim","year":"2015","unstructured":"Naim MY, Gaynor JW, Chen J, et al. Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery [discussion in J Thorac Cardiovasc Surg. 2015;150(1):178\u2013180]. J Thorac Cardiovasc Surg. 2015;150(1):169\u2013178."},{"issue":"1","key":"i2331-348X-30-5-617-b14","series-title":"Am J Med Sci","first-page":"10","article-title":"Diuretic complications","volume":"319","author":"Greenberg","year":"2000","unstructured":"Greenberg A. Diuretic complications. Am J Med Sci. 2000;319(1):10\u201324."},{"issue":"4","key":"i2331-348X-30-5-617-b15","series-title":"N Am J Med Sci","first-page":"170","article-title":"Markers of renal function tests","volume":"2","author":"Gowda","year":"2010","unstructured":"Gowda S, Desai PB, Kulkarni SS, et al. Markers of renal function tests. N Am J Med Sci. 2010;2(4):170\u2013173."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/5\/article-p617.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/5\/article-p617.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/5\/article-p617.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:03:37Z","timestamp":1763762617000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/5\/article-p617.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5863\/jppt-24-00050","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}